leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 17:02:26 - browse：46

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Allen Institute goes after foundational questions, CEO Costa says

leisure time

WSS

Pharma patents targeted by Biden in move to slash drug prices

Ascension's ugly legal battle over care for poor patients in Texas

Spinal cord stimulation reduces pain in amputees, study finds

FDA needs staff influx to meet gene therapy needs, Marks says

Stories you might have missed in 2023: health, science, medicine

Does Paxlovid work in people vaccinated against Covid

knowledge

leisure time

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

What causes an itch? Researchers may have solved the mystery

Wildfire smoke exposes gaps in outdoor worker protections

Teach medical students about patients with intellectual disabilities

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Roche to buy Carmot Therapeutics, developer of obesity drugs

Walensky prepares to leave CDC — and Congress — behind

Pharma patents targeted by Biden in move to slash drug prices

New air purifier tech could be key to improving indoor air quality

Stories you might have missed in 2023: health, science, medicine

knowledge

Arena BioWorks launches in Cambridge to speed drug discovery

Does Paxlovid work in people vaccinated against Covid

STAT letters to the editor on burnt

FDA needs staff influx to meet gene therapy needs, Marks says

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

leisure time

leisure time

focus

entertainment